Drug
13-cis retinoic acid
13-cis retinoic acid is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph phase_2
3
75%
Ph phase_3
1
25%
Phase Distribution
0
Early Stage
3
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
Phase 3Large-scale testing
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 23 (75.0%)
Phase 31 (25.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer
NCT03370367
completedphase_2
RA-4: 13-cis Retinoic Acid for Treatment of Men With Azoospermia
NCT03323801
completedphase_2
RA-2 13-cis Retinoic Acid (Isotretinoin)
NCT02061384
completedphase_2
13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer
NCT00002586
Clinical Trials (4)
Showing 4 of 4 trials
NCT03370367Phase 3
Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer
NCT03323801Phase 2
RA-4: 13-cis Retinoic Acid for Treatment of Men With Azoospermia
NCT02061384Phase 2
RA-2 13-cis Retinoic Acid (Isotretinoin)
NCT00002586Phase 2
13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4